NanoViricides (NNVC) Retains Biologics Consulting Group to Prepare for IND
NanoViricides Inc., a development stage company focused on creating special purpose nanomaterials for viral therapy, today announced its consulting agreement with Biologics Consulting Group Inc. (BCG), in which the two companies will prepare for submission of Investigational New Drug (IND) applications to the U.S. FDA for NanoViricides’ nanoviricides® drug candidates. BCG is an international consulting firm providing national and international regulatory and product development assistance for the development and commercial production of drug, biological and device products. NanoViricides noted the advances and efforts it has made to get its anti-influenza drug candidates to the pre-IND and IND stages. From here…